Madrigal Pharmaceuticals Inc (MDGL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché MDGL Giù? Forum Previsione Frazionamento azionario

Madrigal Pharmaceuticals Inc Azioni (MDGL) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	29.75% 152.04	117.18	98.53	86.45	78.34
Interest Income/Expense	3.35% 3.838	3.971	3.504	2.901	2.336
Operating Income/Loss	29.75% -152.04	-117.18	-98.53	-86.45	-78.34
Income/Loss From Continuing Operations Before Tax	31.51% -147.54	-112.19	-98.74	-85.80	-76.90
Income/Loss From Continuing Operations After Tax	31.51% -147.54	-112.19	-98.74	-85.80	-76.90
Net Income/Loss	31.51% -147.54	-112.19	-98.74	-85.80	-76.90
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.22% 20.00	19.76	18.48	18.31	18.19
Diluted Average Shares	1.22% 20.00	19.76	18.48	18.31	18.19
Basic Earnings Per Share	29.93% -7.38	-5.68	-5.34	-4.69	-4.23
Diluted Earnings Per Share	29.93% -7.38	-5.68	-5.34	-4.69	-4.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%